GEODE CAPITAL MANAGEMENT, LLC - ALBANY MOLECULAR RESH INC ownership

ALBANY MOLECULAR RESH INC's ticker is and the CUSIP is 012423AB5. A total of 18 filers reported holding ALBANY MOLECULAR RESH INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of ALBANY MOLECULAR RESH INC
ValueSharesWeighting
Q1 2017$6,920,000
-53.0%
6,360,000
-44.0%
0.00%
-57.1%
Q4 2016$14,739,000
+26.9%
11,360,000
+15.2%
0.01%
+16.7%
Q3 2016$11,616,000
+21.2%
9,860,000
+5.3%
0.01%
+20.0%
Q2 2016$9,588,000
+44.9%
9,360,000
+56.0%
0.01%
+25.0%
Q1 2016$6,618,000
+9.4%
6,000,000
+33.3%
0.00%
+33.3%
Q4 2015$6,052,0004,500,0000.00%
Other shareholders
ALBANY MOLECULAR RESH INC shareholders Q2 2017
NameSharesValueWeighting ↓
Context Capital Management, LLC 5,625,000$5,815,0006.76%
ALTEGRIS ADVISORS, L.L.C. 500,000$512,0005.92%
Birch Grove Capital LP 8,500,000$8,750,0004.60%
Mohican Financial Management, LLC 3,700,000$3,790,0003.42%
Verition Fund Management LLC 4,500,000$4,632,0000.59%
BASSO CAPITAL MANAGEMENT, L.P. 2,810,000$2,893,0000.45%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 20,000,000$20,688,000,0000.45%
SSI INVESTMENT MANAGEMENT LLC 3,364,000$3,446,0000.33%
WOLVERINE ASSET MANAGEMENT LLC 15,000,000$15,510,0000.24%
PALISADE CAPITAL MANAGEMENT, LP 5,016,000$5,182,0000.19%
View complete list of ALBANY MOLECULAR RESH INC shareholders